International Journal of Diabetes and Clinical Research is a global peer reviewed open access journal that emphasis on the different aspects of clinical diabetes. It highlights the investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes.
Clinical Diabetes acts as platform for the diabetes health care practitioners and clinicians to represent their original work, reviews, commentaries, shorts communications, letters, oral presentations and case studies. The classification terms include but not limited to Type 1 Diabetes, Type 2 diabetes, Diabetes care, Insulin Resistance, Insulinotherapy, Endocrinology, Gestational diabetes, Prediabetes, Metabolic Syndrome, Diabetic risk factors, Blood glucose dynamics and Diabetes- Therapeutic approaches.
International Journal of Diabetes and Clinical Research ensures the faster publication of high quality articles with the support of its eminent Editorial board members. Two independent review comments followed by editor's decision will be considered to publish the article. IJDCR is a permanent archive of Diabetes information which under open access category provides its global readers with free access to its content, thus serving the scientific community.
Liana de Oliveira Gomes, Francislaine Aparecida dos Reis Livero, Aline Maria Stolf, Carlos Eduardo Alves de Souza, Michele Pontes Werneck, Cristiane Vizioli de Castro Ghizoni, Maria Helena Verdan, Jose Ederaldo Queiroz Telles, Rosangela Locatelli Dittrich, Maria Elida Alves Stefanello, Jurandir Fernando Comar and Alexandra Acco
The Safety, Efficacy and Treatment Satisfaction Comparison of Unchanged Premixed Insulin Regimen Plus Sitagliptin with Switch from the Premixed Insulin to Once-Daily Basal Insulin Plus Sitagliptin in Patients with Inadequately Controlled Type 2 Diabetes with Twice-Daily Premixed Insulin
Department of Hematology and Medical Oncology
Emory University School of Medicine